TAT antibody (A00622) performs well in WB and shows reactivity with Human, Mouse, Rat.

  • Validated for inter-lot consistency, specificity, and reproducibility
  • Committed to quality since 1993
  • Over 1 Publication
Filter:
a00622 1 WB anti atty picoband antibody

Anti-ATTY/TAT Antibody Picoband®

TAT antibody

Reactive SpeciesHostApplication
Human, Mouse, RatRabbitWB

SKU: A00622

Size: 100 μg

Bundle to save: I do not want free secondary ab
Price:
$370/100 μg

7 in stock. Ships Next Business Day.

Quantity: 1

1
Get A Quote
Guarantee / Product Promise

Tested Applications

TAT antibody was positively detected by WB in:

rat spleen tissue, mouse liver tissue, A549 whole cell

Suggested blocking solution with 5% non-fat milk or BSA; (*)Recommended protein loading: 20-40 ug per lane

Recommend Dilution

Application
Dilution
Species
Western blot
0.1-0.5μg/ml
Human, Mouse, Rat

* It is recommended to optimize the amount of this reagent in each experimental system to achieve the best results.

Reactive Data

Filter:
Boster Guarantee:What is this?
WB
Rat
Tested
Mouse
Tested
Human
Predicted
Dog
Predicted
Monkey
Predicted
Rabbit
Predicted
Bovine
Predicted
Sheep
Predicted

Product Information

Product Name
Anti-ATTY/TAT Antibody Picoband®
View all TAT Antibodies
Form
Lyophilized
Uniprot
Gene ID
Storage & Handling
Store at -20˚C for one year from date of receipt. After reconstitution, at 4˚C for one month. It can also be aliquotted and stored frozen at -20˚C for six months. Avoid repeated freeze-thaw cycles.
Host
Rabbit
Contents
Each vial contains antibody formulated with stabilizing components, 0.9 mg NaCl, 0.2 mg Na2HPO4, and 0.05 mg NaN3.
*This antibody is supplied in a stabilized formulation.
Compatibility with conjugation reactions depends on the chemistry of the conjugation method used.
For conjugation methods that are not compatible with the stabilizing components present in this formulation, a carrier-free antibody format is required.
Clonality
Polyclonal
Isotype
Rabbit IgG
Immunogen
A synthetic peptide corresponding to a sequence in the middle region of human ATTY, different from the related mouse and rat sequences by two amino acids.
Cross-Reactivity
No cross-reactivity with other proteins.
Reconstitution
Add 0.2ml of distilled water will yield a concentration of 500ug/ml.
Observed Molecular Weight
42 kDa
Calculated Molecular Weight

50.4 kDa

Background of TAT
This nuclear gene encodes a mitochondrial protein tyrosine aminotransferase which is present in the liver and catalyzes the conversion of L-tyrosine into p-hydroxyphenylpyruvate. Mutations in this gene cause tyrosinemia (type II, Richner-Hanhart syndrome), a disorder accompanied by major skin and corneal lesions, with possible mental retardation. A regulator gene for tyrosine aminotransferase is X-linked.
Cite This Product
Anti-ATTY/TAT Antibody Picoband® (Boster Biological Technology, Pleasanton CA, USA, Catalog # A00622)

Protocols

Western Blot protocol for TAT antibody

Publications

Application:
Electroacupuncture Alleviates Surgical Trauma-Induced Hypothalamus Pituitary Adrenal Axis Hyperactivity Via microRNA-142
PMID: 29021740

Review

Have you used Anti-ATTY/TAT Antibody Picoband®?

Submit a review and receive $370 in product credits, a $185 Amazon gift card, or our carefully curated gift bundles.

Product Promise

We promise Anti-ATTY/TAT Antibody Picoband® performs excellently in relevant applications for WB. If it doesn't perform as promised, we will refund the product. Learn more

In stock
Order Product
A00622
Buy one primary antibody get one 0.5ml HRP or Biotin secondary antibody for free.
*Sample sizes are prepared on demand and will take extra lead time. (cannot be conjugated)
$370.00

Troubleshooting

troubleshooting-box-image

Download troubleshooting handbooks for IHC, Western blot and ELISA for FREE.

Download Free PDFs Now

Boster Guarantee

Guaranteed product quality

Guaranteed product quality

We promise all of our products perform as described in datasheets.

This product is for Research Use Only. Not for use in diagnostic procedures.

Update date: Oct 6, 2026